Abstract:Background The facts that LPA is present at high concentration in ovarian cancer patients’ ascites and it may serve as a stimulator to cell migration, implicate the role of LPA in the ovarian cancer metastasis. Since LPA mediates various biological functions through its interaction with LPA receptors, we aim to investigate the correlation between the expression of LPA receptors and the metastasis of ovarian cancer. Methods To test whether the LPA responsiveness correlated with the metastatic capability of ovarian cancer cells, we performed LPA induced invasion assay and peritoneal metastatic colonization assay with a panel of established human ovarian cancer cell lines. The expression of LPAR1-3 in different ovarian cancer lines was examined by qRT-PCR. We also tested the effects of LPAR1 inhibition or overexpression on ovarian cancer cell's invasiveness. To confirm our laboratory results, we detected LPARs expression in specimens from 52 ovarian cancer patients by qRT-PCR and immunohistochemistry. Results Thirteen ovarian cancer cells were enrolled in the invasion assay. Ovarian cancer cell lines which responded well to LPA-induced invasion, also displayed good capability for metastatic colonization. On the contrary, cell lines with poor LPA responsiveness showed inferior metastatic potential in peritoneal colonization assay. High expression level of LPAR1 was detected in all of the metastatic ovarian cancer cell lines. T -test showed that LPAR1, not LPAR2 or LPAR3, expression was significantly higher in the metastatic cell lines than in the non-metastatic cell lines ( P = 0.003). Furthermore, silencing LPAR1 alone could significantly reduce LPA-induced invasion ( P < 0.001). Finally, we analyzed the correlation between the LPARs expression and clinicopathological features of the clinical cases. It indicated that LPAR1 expression rate increased significantly along with the more advanced stages (stage I: 16.67 %; II 50.00 %; III: 75.00 %; and IV: 100.00 %; P = 0.003). Besides that, LPAR1 expression was detected in all the 13 cases with abdominal metastasis more than 2 cm, 10 cases with retroperitoneal lymph node metastasis and 6 cases with hepatic metastasis. Moreover, the expression rate of LPAR2 significantly increased in ovarian cancer than in normal specimens ( P = 0.039). LPAR3 expression showed the same trend as LPAR2, though the difference is not statistically significant ( P = 0.275). Besides that LPAR2 and LPAR3 expression increased along with poorer differentiation ( P = 0.002, P = 0.034, respectively). Conclusions Metastatic capability of ovarian cancer cells correlated well with their responsiveness to LPA for cell invasion. LPAR1 acts as the main mediator responsible for LPA-stimulated ovarian cancer cell invasion. LPAR2 and LPAR3 might play an role in carcinogenesis of ovarian cancer.

LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration

LPA 2 ( EDG 4 ) Mediates Rho-dependent Chemotaxis with Lower Efficacy Than LPA 1 ( EDG 2 ) in Breast Carcinoma Cells

Effect of the LPA-mediated CXCL12-CXCR4 Axis in the Tumor Proliferation, Migration and Invasion of Ovarian Cancer Cell Lines.

Lysophosphatidic Acid Induces the Migration and Invasion of SGC-7901 Gastric Cancer Cells Through the LPA2 and Notch Signaling Pathways

Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA1, p42 and p38α

Cross-Talk Between Lysophosphatidic Acid Receptor. 1 and Tropomyosin Receptor Kinase A Promotes Lung Epithelial Cell Migration

Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.

Toward the Three-Dimensional Structure and Lysophosphatidic Acid Binding Characteristics of the LPA(4)/p2y(9)/GPR23 Receptor: a Homology Modeling Study.

Lysophosphatidic Acid Stimulates Activation of Focal Adhesion Kinase and Paxillin and Promotes Cell Motility, via LPA1–3, in Human Pancreatic Cancer

Lysophosphatidic acid induced HeLa-S3 cell migration

Elucidating the Binding Mechanism of LPA Species and Analogs in an LPA4 Receptor Homology Model

The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration

LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways

LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study

Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways

Disruption of LPA‐LPAR1 Pathway Results in Lung Tumor Growth Inhibition by Downregulating B7‐H3 Expression in Fibroblasts

Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9

Effects of Lysophosphatidic Acid on the Migrations of Hepatoma Cells with Different Metastasis

Lysophosphatidic acid receptor 1 (LPA1) antagonists as potential migrastatics for triple negative breast cancer

LAPTM4B‐35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics

LRP-1 receptor combines EGFR signalling and eHsp90α autocrine to support constitutive breast cancer cell motility in absence of blood supply